#USA #Eden Prairie #DDL Inc #Jennifer Riter #Analytical Testing

DDL Welcomes Jennifer Riter as Vice President of Analytical Testing Services

DDL, a well-known third-party testing laboratory, has announced the appointment of Jennifer Riter as Vice President of Analytical Testing Services. With an impressive background in the pharmaceutical and drug delivery sectors, Riter aims to enhance DDL's capabilities in Good Manufacturing Practice (GMP) testing and consulting for drug-device combination products.

A Leader with Rich Experience

Jennifer Riter's career spans nearly 30 years, bringing a wealth of leadership experience working within analytical services, technical operations, and business strategy. Before joining DDL, she was the Vice President of Analytical and Development Services at Kindeva Drug Delivery. During her tenure at Kindeva, she successfully led global analytical and development teams and greatly expanded the company's analytical testing competencies.

Prior to her role at Kindeva, Riter spent three decades at West Pharmaceutical Services, taking on various senior leadership positions that encompassed analytical services and business operations. Throughout her professional journey, she has demonstrated an exceptional ability to build high-performing teams, launch innovative service offerings, and achieve operational excellence in support of the pharmaceutical industry.

DDL's Vision and Future

In her new role, Riter will not only lead GMP testing initiatives at DDL but will also offer her expertise as a consultant to clients navigating complex drug delivery systems. Key areas of focus include primary closure system strategies and the filling and sealing processes crucial for ensuring product integrity and compliance. Furthermore, she is slated to develop new GMP laboratory capabilities, which include advanced methodologies like the United States Pharmacopeia (USP) 1207 for deterministic Container Closure Integrity testing.

John Koch, General Manager of DDL, expressed enthusiasm for Riter's contributions, stating, "Jennifer's extensive experience in leading analytical testing programs and supporting pharmaceutical innovation makes her an outstanding addition to DDL. Her technical expertise, industry knowledge, and commitment to customer success will help us continue expanding our GMP testing capabilities and delivering exceptional service to our clients."

DDL's Testing Environment

DDL operates out of a spacious 10,600-square-foot FDA-registered laboratory located in Minnetonka, Minnesota, situated near its headquarters in Eden Prairie. The facility is dedicated to ICH stability studies, functional and mechanical performance testing, and simulated distribution testing for a diverse array of products, including auto-injectors, prefilled syringes, inhalers, and other drug-device combinations. This expanded capability strengthens DDL's position as a trusted provider of regulatory-compliant testing services to clients in the pharmaceutical, biotech, and medical device sectors.

Explore the Future with DDL

For those interested in learning more about DDL's GMP testing and consulting services, or to request a quote, the company invites inquiries via their website at www.DDLtesting.com or by calling 800-229-4235.

About DDL

DDL is an independent third-party testing facility known for providing specialized testing in medical devices, combination products, materials, and packaging, primarily serving the life sciences industry. The company operates laboratories in Eden Prairie, MN, Minnetonka, MN, Irvine, CA, and Edison, NJ. To discover more about the various testing services DDL offers, visit www.DDLTesting.com.